Enjoy complimentary customisation on priority with our Enterprise License!
The global flow cytometry market size is estimated to grow by USD 6.04 billion at a CAGR of 13.12% between 2022 and 2027. The market's growth depends on multiple factors, with a notable emphasis on increasing expenditure on R&D, expanding applications for flow cytometry, and continuous technological advancements. This heightened investment in R&D initiatives has catalyzed the emergence of novel applications for flow cytometry, propelling a surge in demand for these sophisticated devices. Consequently, the landscape witnesses a dynamic shift driven by innovation, thereby fostering robust market expansion. This market research and growth report also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
Get Exclusive Sample Copy of this Report
The market share growth by the reagents and consumables segment will be significant during the forecast period. This product segment generated high sales revenue due to the significantly higher volume of sales and the short product replacement or replenishment cycle. The primary functions of these reagents and consumables include Cell separation, Cell detection, Blocking, Cell status analysis, Performance control, and Cell staining. Such factors will increase segment growth during the forecast period.
Get a glance at the market contribution of various segments View PDF Sample
The reagents and consumables segment was valued at USD 2.54 billion in 2017 and continued to grow by 2021. The reagents or markers used to detect molecules and other proteins in cells through various methods usually have a life of one process and cannot be reused as they are absorbed into the cell body. This necessitates the use of new reagents and markers for a subsequent process. The rising number of diagnostic processes in healthcare facilities worldwide has led to a rise in demand for flow cytometry reagents, particularly in the detection of conditions such as cancer and HIV.
The pharmaceutical industry is primarily engaged in the discovery and development of drugs for a wide array of therapeutic applications. The pharmaceutical industry is growing rapidly across the world. The trend of developing personalized medicine acts as one of the major growth opportunities for pharmaceutical companies.
For more insights on the market share of various regions View PDF Sample now!
North America is estimated to contribute 35% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The increasing prevalence of several infectious and chronic diseases, the growing presence of pharmaceutical companies, the rise in the development of various therapeutic drugs, and the growing adoption of advanced technologies are some of the major factors that are expected to drive the growth of the market in North America.
The Global Flow Cytometry Market is experiencing robust growth driven by factors such as Cancer and HIV/AIDS prevalence, advancements in technological flow cytometry instruments, and rising R&D investments in Biotechnology and Life science. Infectious diseases and Immunodeficiency disorders diagnosis has been enhanced with innovative solutions. Point-of-Care (POC) testing, including PCR and Antibody-based testing, is expanding, especially in low- and lower-middle-income countries, aided by government initiatives. The clinical segment benefits from small-sized high-throughput cytometers and cell-based flow cytometry. Our researchers analyzed the data with 2022 as the base year and the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Increasing R&D investment emerges as a pivotal driver for the global market's expansion. Over the past decade, global R&D spending has shown a consistent upward trajectory. The rise in the occurrence of various ailments like Cancer, HIV/AIDS, and COVID-19, alongside conditions such as Immunodeficiency disorders and Infectious diseases, fuels the urgency to develop effective treatments, prompting heightened investment in Biotechnology and Life science sectors.
Pharmaceutical entities prioritize R&D endeavors to enrich their product pipelines, catering to diverse therapeutic needs. A surge in R&D outlays is witnessed as companies strive to innovate and introduce novel drugs. The escalating demand for cutting-edge technologies underscores the significance of this market segment's growth in the foreseeable future.
The increasing level of process automation is the primary trend in the global market growth. Automation is evident in nearly all laboratory processes, including flow cytometry. From using manual sample preparation and loading techniques earlier to now using instruments that are designed to prepare, load, and store samples for the process, the technology and level of automation have improved greatly over the past couple of decades. As these devices have digital interfaces and allow the storage of processed information, they reduce the human intervention required substantially.
The integration of these instruments with other devices and processes can increase flexibility, allow continuous process flow for the samples, and reduce processing time and human supervision. Additionally, most instruments and devices used in a modern laboratory can be integrated into a digital ecosystem to enable seamless integration from one process to the next. This will allow for greater throughput, better accuracy, energy efficiency, reduced wastage of resources, and lower operating costs in the long run. Therefore, the global market is expected to witness high growth during the forecast period.
A shortage of skilled professionals is indirectly polluting the environment, which poses a major challenge to the growth of the global market. Flow cytometry instruments are often large and complex and require sophisticated analysis software for various measurement procedures. This means that the operation of these instruments and the analysis of samples will require the user to gain considerable training. Therefore, companies need to invest heavily in providing training to their employees on how to use these instruments effectively. The limited number of such trained professionals is posing challenges to the growth of the market and will likely continue to do so during the forecast period.
The increasing sophistication of these devices also leads to higher maintenance costs for end-users that rely heavily on them, such as companies in the biopharmaceutical industry. This shortage of skilled labor, combined with the growing sophistication of flow cytometry instruments, will prove to be a challenge to the growth of the market during the forecast period.
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Flow Cytometer Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Amphasys - The company offers flow cytometry such as Ampha X30. Also, the company offers chip-based single-cell analysis technology products.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The Global Flow Cytometry Market is experiencing significant growth due to increased focus on addressing Immunodeficiency disorders and Infectious diseases. With substantial R&D investments and Biopharmaceutical research activities, the market witnesses advancements in Flow cytometry instruments including Microfluidic flow cytometry and Point-of-Care (POC) testing technologies like PCR and Antibody-based testing, crucial for diseases like AIDS, Tuberculosis, and Sexually transmitted diseases particularly in Low- and lower-middle-income countries. Government initiatives drive the adoption of PoC diagnostics and support the development of Small-sized high-throughput cytometers such as CGX10 and offerings from Sony Biotechnology, Inc. and BD. The market caters to diverse sectors including the Clinical segment with solutions from Beckman Coulter and CellMek SPS, and the Industrial segment along with contributions from Academic institutes and Clinical testing labs.
The market is witnessing rapid growth, driven by significant technological advancements in cell analysis and diagnostics. Cell-based flow cytometry and bead-based assays have revolutionized research in areas like HIV/AIDS and cancer research. The market offers various technological flow cytometry instruments, including cell sorters and cell analyzers, catering to diverse needs. While the cost of instruments remains a concern, public-private funding initiatives and financial support have facilitated product installation and reduced expenditure costs. Developments in stem cell research and regulatory environments have fueled demand, particularly in developing nations. Multiparametric data analysis, use of fluorescent-labeled antibodies, and fluorescent-labeled compounds highlight the market's sophistication, serving academic & research institutes, hospitals & clinical testing laboratories, and pharmaceutical & biotechnology companies alike, in advancing drug discovery services and HIV research.
The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Flow Cytometry Market Scope |
|
Report Coverage |
Details |
Page number |
168 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 13.12% |
Market growth 2023-2027 |
USD 6.04 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
12.09 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 35% |
Key countries |
US, Canada, UK, Germany, and China |
Competitive landscape |
Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, Agilent Technologies Inc., Amphasys AG, Apogee Flow Systems Ltd., Becton Dickinson and Co., Bio Rad Laboratories Inc., Cytek Biosciences Inc., Danaher Corp., DiaSorin SpA, Enzo Biochem Inc., Miltenyi Biotec B.V. and Co. KG, Mindray Bio medical Electronics Co. Ltd, OLS OMNI Life Science GmbH and Co. KG, Onchip Biotechnology Co. Ltd.Corp., Sartorius AG, Sony Group Corp., Stratedigm Inc., Sysmex Corp., Thermo Fisher Scientific Inc., and Union Biometrica Inc. |
Market dynamics |
Market trends and analysis, Market growth inducers and obstacles and accessories, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
To get detailed analysis Buy Now Full Report PDF
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.